These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Effect of captopril on blood pressure and renal function in patients with transplant renal artery stenosis. van der Woude FJ, van Son WJ, Tegzess AM, Donker AJ, Slooff MJ, van der Slikke LB, Hoorntje SJ. Nephron; 1985; 39(3):184-8. PubMed ID: 2983251 [Abstract] [Full Text] [Related]
28. Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension. Curtis JJ, Luke RG, Whelchel JD, Diethelm AG, Jones P, Dustan HP. N Engl J Med; 1983 Feb 17; 308(7):377-81. PubMed ID: 6337328 [No Abstract] [Full Text] [Related]
29. [Administration of angiotensin I converting enzyme inhibitor captopril, in a case of renal crisis of scleroderma--the effects of captopril to the temperature of the skin lesion in scleroderma (author's transl)]. Gotoh S, Ogihara T, Hata T, Maruyama A, Naka T, Nakamaru M, Mikami H, Masuo K, Kumahara Y. Nihon Jinzo Gakkai Shi; 1981 Aug 17; 23(8):1133-41. PubMed ID: 7033607 [No Abstract] [Full Text] [Related]
30. Risks of angiotensin converting enzyme inhibition in renal artery stenosis. Wenting GJ, Derkx FH, Tan-Tjiong LH, van Seyen AJ, Man in't Veld AJ, Schalekamp MA. Kidney Int Suppl; 1987 May 17; 20():S180-3. PubMed ID: 3037168 [No Abstract] [Full Text] [Related]
31. [Reversible renal insufficiency and arterial hypertension after renal transplantation: role of transplant artery stenosis and a captopril-furosemide combination]. Suc JM, Vernier I, Durand D, Giraud P, Segonds-Modesto A, Sarramon JP. Nephrologie; 1985 May 17; 6(3):155-8. PubMed ID: 3908959 [Abstract] [Full Text] [Related]
32. Deterioration of renal function in hypertensive patients with scleroderma despite blood pressure normalization with captopril. Waeber B, Schaller MD, Wauters JP, Brunner HR. Klin Wochenschr; 1984 Aug 01; 62(15):728-30. PubMed ID: 6387262 [Abstract] [Full Text] [Related]
34. Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease. Sinaiko AR, Mirkin BL, Hendrick DA, Green TP, O'Dea RF. J Pediatr; 1983 Nov 01; 103(5):799-805. PubMed ID: 6355421 [Abstract] [Full Text] [Related]
35. Transient anuria following administration of angiotensin I-converting enzyme inhibitor (SQ 14225) in a patient with renal artery stenosis of the solitary kidney successfully treated with renal autotransplantation. Kawamura J, Okada Y, Nishibuchi S, Yoshida O. J Urol; 1982 Jan 01; 127(1):111-3. PubMed ID: 7035691 [Abstract] [Full Text] [Related]
36. [Reversible panmyelopathy following captopril treatment]. Iro H, Henschke F, König HJ. Dtsch Med Wochenschr; 1986 Jan 24; 111(4):139-41. PubMed ID: 3510849 [Abstract] [Full Text] [Related]
37. Captopril slows the progression of chronic renal disease in partially nephrectomized rats. Hall RL, Wilke WL, Fettman MJ. Toxicol Appl Pharmacol; 1985 Sep 30; 80(3):517-26. PubMed ID: 3898470 [Abstract] [Full Text] [Related]
38. Postpartum renal failure and malignant hypertension treated with captopril. Rasmussen S, Brahm M, Nielsen MD, Giese J, Larsen S, Brun C. Scand J Urol Nephrol; 1983 Sep 30; 17(2):209-12. PubMed ID: 6351239 [Abstract] [Full Text] [Related]
39. Successful use of captopril in the treatment of "scleroderma renal crisis". Chapman PJ, Pascoe MD, van Zyl-Smit R. Clin Nephrol; 1986 Aug 30; 26(2):106-8. PubMed ID: 3530566 [Abstract] [Full Text] [Related]
40. [Captopril and renal transplant]. Cuevas J, Lloveras J, Aubia J, Masramon J. Med Clin (Barc); 1985 Jan 19; 84(2):82-3. PubMed ID: 3883069 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]